{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:14:03Z","timestamp":1781576043875,"version":"3.54.5"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"14","license":[{"start":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T00:00:00Z","timestamp":1468540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Ministero della Salute (Ministry of Health, Italy), Ricerca Corrente","award":["08069614"],"award-info":[{"award-number":["08069614"]}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute (Ministry of Health, Italy), Ricerca Finalizzata","doi-asserted-by":"publisher","award":["GR-2010"],"award-info":[{"award-number":["GR-2010"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["93043\/A"],"award-info":[{"award-number":["93043\/A"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2012-0626"],"award-info":[{"award-number":["2012-0626"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2016,7,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Human cytomegalovirus (HCMV) may cause disseminated\/end-organ disease in congenitally infected newborns and immunosuppressed transplant recipients. Two glycoprotein complexes, gH\/gL\/gO and gH\/gL\/pUL128\/pUL130\/pUL131 (gH\/gL\/pUL128L; referred to as the pentamer), are required for HCMV entry into fibroblasts and endothelial\/epithelial cells, respectively, in the presence of the viral fusion protein gB. In addition, gH\/gL\/gO was recently reported to also be required for infection of endothelial\/epithelial cells. Virus entry into human fibroblasts involves fusion of the virus envelope with the plasma membrane, whereas entry into endothelial\/epithelial cells involves macropinocytosis or endocytosis and low-pH-dependent fusion with endosomes. A large set of neutralizing monoclonal antibodies (MAbs), directed to gH, gB, and multiple components of the pentamer, was developed. In addition, novel anti-gO human monoclonal antibodies were recently isolated. It is known that epithelial cell infection with a wild HCMV strain at a high multiplicity of infection produces a large number of syncytia. Incubation of heavily HCMV VR1814-infected ARPE-19 epithelial cells with neutralizing MAbs to one, two, or three components of the pUL128L portion of the pentamer blocked syncytium formation at an antibody concentration of 10 \u03bcg\/ml, whereas only a partial inhibitory effect was displayed for MAbs to gO, gH, or gB at the same concentration. A blocking effect was also exhibited by convalescent-phase sera from primary HCMV infections. These findings indicate that the pentamer is required for syncytium formation in epithelial cells.<\/jats:p>\n          <jats:p>\n            <jats:bold>IMPORTANCE<\/jats:bold>\n            Human cytomegalovirus (HCMV) mostly infects epithelial and endothelial cells\n            <jats:italic>in vivo<\/jats:italic>\n            . Recently, the pentamer protein complex (gH\/gL\/pUL128L) was identified as being required for infection of these cells, in association with the other protein complex, gH\/gL\/gO. In primary infections, HCMV migrates to endothelial cells and then to leukocytes, which disseminate the infection throughout the body. The virus then spreads to organs and tissues, mostly infecting either single cells or multinucleated epithelial giant cells (syncytia), depending on the viral load. Potent neutralizing human MAbs directed to distinct binding sites of the pUL128L portion of the pentamer were shown in the past to block virus dissemination. In the present study, MAbs to pUL128L were shown to block syncytium formation with a higher potency than that of MAbs to gO, gH, or gB, thus suggesting their role in limiting virus dissemination. This finding provides additional information useful for the development of anti-HCMV therapeutic antibodies and subunit vaccines.\n          <\/jats:p>","DOI":"10.1128\/jvi.00121-16","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T16:39:05Z","timestamp":1461861545000},"page":"6216-6223","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":77,"title":["Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH\/gL\/pUL128L and Trimer gH\/gL\/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation"],"prefix":"10.1128","volume":"90","author":[{"given":"Giuseppe","family":"Gerna","sequence":"first","affiliation":[{"name":"Laboratori Sperimentali di Ricerca, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Percivalle","sequence":"additional","affiliation":[{"name":"Struttura Complessa di Microbiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Perez","sequence":"additional","affiliation":[{"name":"Universit\u00e0 della Svizzera Italiana (USI), Institute for Research in Biomedicine, Bellinzona, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lanzavecchia","sequence":"additional","affiliation":[{"name":"Universit\u00e0 della Svizzera Italiana (USI), Institute for Research in Biomedicine, Bellinzona, Switzerland"},{"name":"Institute of Microbiology, ETH Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Lilleri","sequence":"additional","affiliation":[{"name":"Laboratori Sperimentali di Ricerca, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/421999"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1633"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.80474-0"},{"key":"e_1_3_2_5_2","first-page":"63","article-title":"Cytomegalovirus cell tropism","volume":"325","author":"Sinzger C","year":"2008","unstructured":"Sinzger C, Digel M, Jahn G. 2008. Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 325:63\u201383.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.18.10023-10033.2004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.16.10330-10338.2005"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509201102"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804365105"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1424818112"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02249-09"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01325-15"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00284-15"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1419875112"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.83523-0"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059863"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1415310111"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01809-09"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00467-12"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316517110"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01669-12"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.05.004"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00332-13"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005230"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01623-08"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004640"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709704104"},{"key":"e_1_3_2_28_2","first-page":"127","article-title":"Cytomegalovirus infection of cerebral astrocytoma in an AIDS patient","volume":"10","author":"Ho KL","year":"1991","unstructured":"Ho KL, Gottlieb C, Zarbo RJ. 1991. Cytomegalovirus infection of cerebral astrocytoma in an AIDS patient. Clin Neuropathol 10:127\u2013133.","journal-title":"Clin Neuropathol"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-198812000-00009"},{"key":"e_1_3_2_30_2","first-page":"825","volume-title":"Clinical hepatology: principles and practice of hepatobiliary disease","author":"Dancygier H","year":"2009","unstructured":"Dancygier H. 2009. Clinical hepatology: principles and practice of hepatobiliary disease, vol 2, p 825. Springer Science & Business Media, Berlin, Germany."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/9781118512074","volume-title":"Yamada's textbook of gastroenterology","author":"Podolski DK","year":"2015","unstructured":"Podolski DK, Camilleri M, Fitz JG, Kalloo AN, Shanahan F, Wang TC. 2015. Yamada's textbook of gastroenterology, vol 2, p 1914. John Wiley & Sons, Hoboken, NJ."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08150"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.11.3198-3204.1998"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(83)90409-9"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00121-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00121-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T14:08:11Z","timestamp":1646489291000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.00121-16"}},"subtitle":[],"editor":[{"given":"K.","family":"Frueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,7,15]]}},"alternative-id":["10.1128\/JVI.00121-16"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00121-16","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,15]]},"assertion":[{"value":"2016-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}